Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells

• Alboukadel Kassambara,

  Affiliation INSERM, U1040, Montpellier, France

  ⨯
• Matthieu Schoenhals,

  Affiliation INSERM, U1040, Montpellier, France

  ⨯
• Jérôme Moreaux,

  Affiliation CHU Montpellier, Institute of Research in Biotherapy, Montpellier, France

  ⨯
• Jean-Luc Veyrune,

  Affiliation CHU Montpellier, Institute of Research in Biotherapy, Montpellier, France

  ⨯
• Thierry Rème,

  Affiliation INSERM, U1040, Montpellier, France

  ⨯
• Hartmut Goldschmidt,

  Affiliation Medizinische Klinik V, Universitätsklinikum Heidelberg and Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany

  ⨯
• Dirk Hose,

  Affiliation Medizinische Klinik V, Universitätsklinikum Heidelberg and Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany

  ⨯
• Bernard Klein

  * E-mail: bernard.klein@inserm.fr

  Affiliations INSERM, U1040, Montpellier, France, CHU Montpellier, Institute of Research in Biotherapy, Montpellier, France, Université MONTPELLIER1, UFR Médecine, Montpellier, France

  ⨯